![]() |
市場調查報告書
商品編碼
2147150
十二指腸內視鏡市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測Duodenoscopes Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球十二指腸內視鏡市場價值為10.8億美元。預計該市場將從2026年的11.6億美元成長到2034年的22.2億美元,在2026年至2034年的預測期內,CAGR為8.4%。北美在2025年引領市場,佔37.04%的市場佔有率,區域市場規模約4億美元。
十二指腸內視鏡是一種專用的軟式內視鏡,主要用於內視鏡逆行性胰膽管攝影術(ERCP),以診斷和治療影響膽管、胰管、十二指腸和乳頭的疾病。膽道疾病、胰臟疾病、膽結石、狹窄、腫瘤和胃腸道疾病病例的不斷增加推動市場擴張。
十二指腸內視鏡市場趨勢
混合安全設計正吸引市場關注。
市場的關鍵趨勢是從傳統的可重複使用十二指腸內視鏡轉向混合安全型內視鏡。這包括帶有拋棄式遠端帽的可重複使用內視鏡、完全拋棄式使用的內視鏡以及與先進滅菌系統相容的可重複使用內視鏡。醫院越來越重視無菌保證、易於清潔、改進的鏡尖操作、使用拋棄式零件以及簡化的再處理流程。這種轉變迫使製造商不僅要在影像品質和操作性方面競爭,還要在感染預防和永續性競爭。
市場促進因素
ERCP手術量的增加推動市場成長。
內視鏡逆行性胰膽管攝影術(ERCP)的需求不斷成長是推動市場發展的主要因素之一。 ERCP廣泛用於治療膽結石、胰膽管狹窄、腫瘤、胰臟炎併發症和膽管阻塞。此手術正逐漸從診斷目的轉向治療性介入,例如取石、支架置入、括約肌切開術和引流。
日益增強的感染控制意識也推動了對拋棄式零件、檢驗的滅菌流程和拋棄式十二指腸內視鏡的需求。
市場限制因素
高成本和複雜的再處理流程阻礙了其廣泛應用。
可重複使用的十二指腸內視鏡需要在再處理系統、維護、熟練人員、儲存、維修和合規文件等方面投入大量資金。雖然拋棄式系統可以降低污染風險,但其高昂的單次使用成本可能會限制其在高流量、價格敏感型醫療機構的應用。
此外,監測培養、內視鏡運作、人員資源和感染控制等相關成本也是採購的挑戰。
市場機會
消毒和拋棄式平台創造了成長機會。
無菌、拋棄式及可消毒重複使用的十二指腸內視鏡的日益普及為製造商帶來了巨大的商機。拋棄式內視鏡尤其適用於急診手術、免疫力缺乏患者、污染風險較高的病例。醫院也對兼具傳統內視鏡性能和更高感染控制保障的可消毒重複使用解決方案表現出濃厚的興趣。
市場挑戰
嚴格的法規和複雜的清潔要求仍然是市場面臨的重大挑戰。十二指腸內視鏡的升降機構和遠端難以清潔和驗證。產品召回、監管警告、員工培訓要求、拋棄式內視鏡相關的環境問題以及保險償付限制也會影響購買決策。
依產品類型分類,到2025年,可重複使用的十二指腸鏡將佔據最大的市場佔有率,這主要得益於其大規模的應用記錄以及在頻繁開展ERCP的醫療機構中的成熟使用。然而,拋棄式十二指腸鏡預計也將實現強勁成長,預測期內的CAGR將達到12.2%。
依應用領域分類,到2025年,治療領域將佔據市場主導地位,這主要得益於ERCP在取石、引流、支架置入、狹窄擴張和其他胰膽手術中應用日益廣泛。診斷領域預計將以6.9%的CAGR成長。
依最終用戶分類,預計醫院和門診手術中心(ASC)將在2025年佔據最大佔有率,預計到2026年將佔市場佔有率的84.6%。專科診所預計將以 10.6%的CAGR成長。
北美市場在2025年達到4億美元,高於2024年的3.7億美元,成為全球市場主導力量。美國市場預計在2026年達到4億美元,約佔全球銷售額的34.3%。
預計2026年,歐洲市場規模將達到3.4億美元,年複合成長率為7.2%。預計到2026年,德國和英國規模將分別達到約7,000萬美元和5,000萬美元。
預計2026年,亞太地區市場規模將達3.2億美元,成為全球第三大區域市場。其中,中國、日本和印度的市場規模預計分別約為1.2億美元、1.1億美元和3,000萬美元。
預計到2026年,拉丁美洲市場規模將達到約 4,000萬美元,而海灣合作理事會市場規模預計將達到約 1,000萬美元。
The global duodenoscopes market size was valued at USD 1.08 billion in 2025. The market is projected to grow from USD 1.16 billion in 2026 to USD 2.22 billion by 2034, exhibiting a CAGR of 8.4% during the 2026-2034 forecast period. North America dominated the market with a 37.04% share in 2025, reaching a regional market value of approximately USD 0.40 billion.
Duodenoscopes are specialized flexible endoscopes primarily used during Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures to diagnose and treat conditions affecting the bile duct, pancreatic duct, duodenum, and papilla. Rising cases of biliary disorders, pancreatic diseases, gallstones, strictures, tumors, and gastrointestinal conditions are supporting market expansion.
Duodenoscopes Market Trends
Hybrid Safety Designs Gain Market Attention
A major trend in the market is the transition from conventional reusable duodenoscopes toward hybrid safety models. These include reusable scopes with disposable distal caps, fully single-use devices, and reusable scopes compatible with advanced sterilization systems. Hospitals are increasingly prioritizing sterility assurance, easier cleaning, improved distal-end access, disposable components, and simplified reprocessing workflows. This shift is also encouraging manufacturers to compete on infection prevention and sustainability in addition to image quality and handling.
Market Drivers
Rising ERCP Procedures Support Market Growth
Increasing demand for ERCP procedures is one of the primary market drivers. ERCP is widely used to treat gallstones, pancreaticobiliary strictures, tumors, pancreatitis complications, and bile duct obstructions. The procedure has increasingly shifted from diagnostic use toward therapeutic interventions such as stone extraction, stent placement, sphincterotomy, and drainage.
Growing infection-control awareness is also driving demand for disposable components, validated sterilization processes, and single-use duodenoscopes.
Market Restraints
High Cost and Complex Reprocessing Limit Adoption
Reusable duodenoscopes require substantial investment in reprocessing systems, maintenance, trained personnel, storage, repair, and compliance documentation. Although single-use systems reduce contamination concerns, their higher per-procedure costs can restrict adoption among high-volume and price-sensitive healthcare facilities.
Additional costs related to surveillance cultures, scope downtime, staff resources, and infection management also create procurement challenges.
Market Opportunities
Sterile and Single-Use Platforms Create Growth Opportunities
Growing adoption of sterile, disposable, and sterilizable reusable duodenoscopes presents strong opportunities for manufacturers. Single-use devices are particularly useful for urgent procedures, immunocompromised patients, and high-risk cases where contamination concerns are significant. Hospitals are also showing interest in sterilizable reusable solutions that combine familiar clinical performance with improved infection-control assurance.
Market Challenges
Stringent regulations and complex cleaning requirements remain important market challenges. The elevator mechanism and distal end of duodenoscopes can be difficult to clean and validate. Product recalls, regulatory warning letters, staff training requirements, environmental concerns associated with disposable scopes, and reimbursement limitations can also affect purchasing decisions.
By product type, reusable duodenoscopes held the largest market share in 2025 due to their large installed base and established use across high-volume ERCP centers. However, disposable duodenoscopes are projected to grow at a strong 12.2% CAGR during the forecast period.
By application, the therapeutic segment dominated in 2025, supported by growing use of ERCP for stone extraction, drainage, stenting, stricture dilation, and other pancreaticobiliary procedures. The diagnostic segment is projected to grow at a 6.9% CAGR.
By end-user, hospitals & ASCs held the largest share in 2025 and are expected to account for 84.6% of the market in 2026. Specialty clinics are projected to expand at a 10.6% CAGR.
North America dominated with USD 0.40 billion in 2025, compared with USD 0.37 billion in 2024. The U.S. market is projected to reach USD 0.40 billion in 2026, representing around 34.3% of global revenues.
Europe is expected to reach USD 0.34 billion in 2026 and grow at a 7.2% CAGR. Germany and the U.K. are projected to reach approximately USD 0.07 billion and USD 0.05 billion, respectively, in 2026.
Asia Pacific is projected to reach USD 0.32 billion in 2026, making it the third-largest regional market. China, Japan, and India are estimated at approximately USD 0.12 billion, USD 0.11 billion, and USD 0.03 billion, respectively.
Latin America is estimated to reach approximately USD 0.04 billion in 2026, while the GCC market is projected at around USD 0.01 billion.
Competitive Landscape
Major companies include Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, PENTAX Medical, Ambu A/S, SonoScape Medical Corp, Ottomed, MITRA Industries, and KARL STORZ SE & Co. KG. Olympus, Boston Scientific, and Ambu held prominent positions in 2025 due to strong brand recognition, broad portfolios, innovation, and geographic presence.
Key Industry Developments
In January 2026, ASP announced CE marking for its ULTRA GI Cycle for duodenoscopes in partnership with FUJIFILM Healthcare Europe. During 2025, FUJIFILM expanded its ED-840T duodenoscope, while PENTAX Medical and ASP launched a sterilizable duodenoscope in the U.S. Ambu also expanded its aScope Duodeno 2 platform following regulatory clearances.
Conclusion
The duodenoscopes market is expected to expand steadily as ERCP procedure volumes rise and healthcare providers place greater emphasis on infection prevention and procedural safety. The market increases from USD 1.08 billion in 2025 to USD 1.16 billion in 2026 and is projected to reach USD 2.22 billion by 2034, at a CAGR of 8.4%. Growing adoption of single-use systems, hybrid safety designs, advanced sterilization technologies, and therapeutic ERCP procedures will remain central to market growth through 2034.
Segmentation By Product Type, Application, End-user, and Region
By Product Type
By Application
By End-user
By Region